Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Junshi Biosciences (1877 HK)
Watchlist
212
Analysis
Health Care
•
China
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Jiangsu Hengrui Medicine
•
04 May 2022 08:51
Jiangsu Hengrui Medicine (600276.CH) 2021/2022Q1 Results - Can You Afford to Wait?
Hengrui's 2021, 2021Q4 and 2022Q1 reports are the worst ever. We updated our views on possible future development trajectory of Hengrui's...
Xinyao (Criss) Wang
Follow
300 Views
Share
bearish
•
Quantitative Analysis
•
24 Apr 2022 16:43
A-H Premium Weekly: China Southern, Shanghai Junshi, Shanghai Haohai, Shanghai Fudan
A-H premium declined by 5.7ppt last week, real estate, consumer discretionary and information technology led the decline. We highlight China...
Ke Yan, CFA, FRM
Follow
291 Views
Share
bearish
•
Quantitative Analysis
•
17 Apr 2022 15:13
A-H Premium Weekly: Real Estate, Industrials, Utilities Led the Decline
Real estate sector led the weekly A-H premium decline. In addition, we highlight A-H premium changes in stocks including Shanghai Junshi...
Ke Yan, CFA, FRM
Follow
331 Views
Share
bearish
•
Thematic (Sector/Industry)
•
17 Apr 2022 09:23
China Healthcare Weekly (Apr.15)- 2022 VBP Focus, Post-COVID IVD Outlook, Undervalued Medical Device
The focus of 2022 VBP was finalized. In post-COVID era, how would cash-rich IVD companies with find new growth point?After continuous pullback,...
Xinyao (Criss) Wang
Follow
354 Views
Share
bearish
•
Zai Lab Ltd
•
11 Apr 2022 08:52
Zai Lab Ltd (ZLAB.US/9688.HK) - Will Zai Lab Go into a Vicious Circle?
Due to increasing cost and potential legal risks, relying on license-in mode is not as glamorous as before.The transition to independent R&D takes...
Xinyao (Criss) Wang
Follow
330 Views
Share
First
Previous
17
18
19
20
21
22
23
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x